To view previous transcripts, check our list of recent broadcasts or select a year below to view older transcripts. Also, search recent transcripts by keyword or visit our searchable archives hosted by Quote.com.

Select a year: 2001 2002 2003 2004


Program: Tuesday, November 15, 2005

Ben Bernanke Faces The Senate Banking Committee
The Latest Economic Forecast Calls For Mild Inflation
One On One With GlaxoSmithKline CEO Jean-Pierre Garnier
"Las Vegas on a Roll,"-Part 4: The Condo Craze Reaches New Heights
"Commentary"-Time To Reel In Federal Budget Policy
Paul Kangas' Stocks In The News
Market Stats

11/15/05: Ben Bernanke Faces The Senate Banking Committee

SUSIE GHARIB: Ben Bernanke pledged today to carry on Alan Greenspan`s policy of fighting inflation. Bernanke, the Bush administration`s chief economist and nominee to replace Greenspan as chairman of the Fed, also told members of the Senate Banking Committee that he would make sure the central bank stays free of political influence. Washington bureau chief Darren Gersh reports.

DARREN GERSH, NIGHTLY BUSINESS REPORT CORRESPONDENT: One of the biggest questions about Ben Bernanke is whether he has the political skills to navigate Washington`s treacherous waters. His confirmation hearing should help put that concern to rest.

SEN. JOHN SUNUNU, (R) NEW HAMPSHIRE: I get the sense that you`ve put on some sort of a charm offensive over these past weeks.

GERSH: Charming Congress is an unwritten requirement for a successful Fed chairman and Bernanke is clearly off to a strong start. Senators praised the plainspoken Princeton economist who reassured lawmakers he would not skew Fed policy to please the White House where he now works.

BEN BERNANKE, FED CHAIRMAN NOMINEE: I assure this committee that, if I am confirmed, I will be strictly independent of all political influences.

GERSH: Bernanke also clarified how monetary theory will guide his actions at the Fed. While a strong advocate of setting numerical inflation targets, Bernanke assured Congress he will not adhere to a rigid rule. Judgment and flexibility he says are critical.

BERNANKE: We`ve seen for example in the last 20 years that the economy`s become more stable. I attribute that to the maintenance of stable inflation and inflation expectations, so in that respect, the inflation targeting ideas that I`ve espoused are simply an attempt to perhaps codify or strengthen this important commitment of this Federal Reserve to maintaining low inflation.

GERSH: Bernanke promised he would not make any significant change in the overall approach to Fed policy developed under Alan Greenspan. Still, some Democrats worry inflation targeting places the Fed`s goal of fighting inflation above it`s other statutory requirement to maintain maximum employment. Bernanke argues targeting a low inflation rate will nurture a strong economy and boost job creation.

BERNANKE: I am entirely in favor of maximum employment. I believe this is a method to achieve it. If I did not think it was, I would not pursue it.

GERSH: Bernanke also pledged to make the Fed more open and transparent, though he drew the line at televising Fed meetings. Darren Gersh, NIGHTLY BUSINESS REPORT, Washington.


Nightly Business Report transcripts are available on-line post broadcast. The program is transcribed by eMediaMillWorks. Updates may be posted at a later date. The views of our guests and commentators are their own and do not necessarily represent the views of Community Television Foundation of South Florida, Inc. Nightly Business Report, or WPBT. Information presented on Nightly Business Report is not and should not be considered as investment advice. Copyright
(c) 2005 Community Television Foundation of South Florida, Inc. ALL RIGHTS RESERVED. Terms of use.


11/15/05: The Latest Economic Forecast Calls For Mild Inflation

JEFF YASTINE: Well, if Federal Reserve policymakers didn`t get a surprise from today`s report on the economy, well economists certainly did. The October reading of producer prices came as a bit of a shock when it was rolled out this morning. But as Scott Gurvey explains, a more detailed analysis of the numbers paints a milder picture of inflation.

SCOTT GURVEY, NIGHTLY BUSINESS REPORT CORRESPONDENT: It was an unexpected report on wholesale prices and most economists found their forecasts way off. Wall Street had anticipated a flat headline number. Instead, the Labor Department reported that overall prices rose 7/10 of 1 percent in October after gaining 1.9 percent in September. Energy prices were responsible. Instead of moderating as expected, they gained another 4.1 percent, with the biggest increase coming in a 20 percent jump in the price of natural gas. But in another surprise, prices for new automobiles and trucks fell sharply in the month. That helped push the so-called core inflation rate down 0.3 percent.

DREW MATUS, SENIOR MARKET ECONOMIST, LEHMAN BROTHERS: Auto prices and truck prices declined and that`s not likely something that`s sustainable over the long run. So it gave us a little bit of a breather regarding the inflation picture, took some of the pressure off. But it doesn`t take it off in the longer term. Inflation still remains a threat to the economy.

GURVEY: Core inflation is now running at 2 percent year over year and that`s right on the Fed`s inflation target. With the price of materials used in manufacturing starting to rise, Fed watchers say they believe the central bank will maintain its policy of raising interest rates at a steady pace to ward off inflation.

DEAN MAKI, CHIEF U.S. ECONOMIST, BARCLAYS CAPITAL: We have seen over the past several months commodity prices rising significantly. This keeps the Fed concerned about the possibility that this is going to pass through to the retail level, that core retail prices will start to rise. We haven`t seen that significantly at this point, but it will remain a concern for some time.

GURVEY: For consumers, the key question is how much of the rising energy prices will be passed on. The consumer price index report is due tomorrow and overall, prices are expected to remain unchanged. Scott Gurvey, NIGHTLY BUSINESS REPORT, New York.

Nightly Business Report transcripts are available on-line post broadcast. The program is transcribed by eMediaMillWorks. Updates may be posted at a later date. The views of our guests and commentators are their own and do not necessarily represent the views of Community Television Foundation of South Florida, Inc. Nightly Business Report, or WPBT. Information presented on Nightly Business Report is not and should not be considered as investment advice. Copyright (c) 2005 Community Television Foundation of South Florida, Inc. ALL RIGHTS RESERVED. Terms of use.

11/15/05: One On One With GlaxoSmithKline CEO Jean-Pierre Garnier

SUSIE GHARIB: Shares of British drug giant Glaxosmithkline have been moving higher this year on hopes its pipeline of new drugs could become blockbusters. CEO Jean-Pierre Garnier will be in New York November 30 to talk with analysts about Glaxo`s outlook. When I spoke with him recently, he gave NIGHTLY BUSINESS REPORT a preview of what he`ll tell investors.

JEAN-PIERRE GARNIER, GLOBAL CEO, GLAXOSMITHKLINE: It happened to be a review of our oncology pipeline of new drugs. So it`s a very specialized workshop with the financial analysts and they`re going to be able to see for themselves the tremendous progress we`ve made in developing new oncology products, new products for cancer. And I think they will be very pleased.

GHARIB: Mr. Garnier, I understand that you met with President Bush a few weeks ago to talk about plans and ways that Glaxo and other drug companies can respond to a potential flu pandemic. Where does Glaxo stand in developing a flu vaccine?

GARNIER: Well, we are very encouraged because we have a prototype so- called h5n1 vaccine in the clinic and we should be ending the development plan of this particular pandemic vaccine by mid next year and then submit it to the authorities, FDA and the like. So we should be in a position to start making stocks of this pandemic vaccine by late 2006. Of course, that assumes that the pandemic does not break before that.

GHARIB: You mentioned oncology in your first response. I want to talk to you about your cervical cancer vaccine. How close are you to getting approval in Europe and in the U.S. for that vaccine and how big a market is there for it?

GARNIER: Well, we are a couple of years away from introducing the vaccine. The clinical trials are going on very well and the product is very effective, very safe. Frankly, it`s going to be a product that is of interest to all women, because they`re all at risk for cervical cancer and cervical cancer is the second most common killer of females in terms of cancers. And we need to have a product that can protect you and that`s what it is.

GHARIB: Well, considering your timetable though, do you think that Merck will have a leg up on you, because they`re coming out with their cervical cancer vaccine Gardasil pretty soon.

GARNIER: Well, I think in the U.S., they might be first. In Europe and international, I think we`re ahead. We`re pretty much at the same time, but it doesn`t matter because demand will be such that frankly it`s a good thing that there would be too producers of this vaccine.

GHARIB: Now, besides vaccines, where do you see Glaxo`s growth coming from in the years ahead?

GARNIER: Well, we have a pipeline that has enormous diversity from central nervous systems drugs to vaccines to oncology to cardiovascular so basically new products. It`s a new product story. We have what is rated by the financial analyst the best pipeline of new drugs in the industry and when everybody is complaining about the R&D productivity, we took action 10 years ago and we finally are seeing the fruits of our efforts. We`ve worked very hard to change the R&D process and to produce new products and new vaccines and we are now seeing those products come through.

GHARIB: As you know, many of the big pharmaceutical companies in the United States are dealing with issues of generic competition, some pipeline issues. What are the challenges for Glaxo in the next five, 10 years?

GARNIER: Well, first of all, we`ve lost in the last five years our top three products to the generics, so we know what it takes and it took a lot of effort and new drugs to be able to stay afloat and continue to grow despite those tremendous hits. We will continue to lose a few drugs in the near future, but frankly nothing substantial in terms of the size of the company and again, we think we can replace that business with new products and new vaccines. So we`re very comfortable about our product cycle for the years to come, but this is a business that is very tough. Once a drug goes generic, it disappears overnight and you lose billions of dollars very quickly.

GHARIB: Mr. Garnier, thank you so much for coming on our program. We really appreciate your time.

GARNIER: My pleasure.

Nightly Business Report transcripts are available on-line post broadcast. The program is transcribed by eMediaMillWorks. Updates may be posted at a later date. The views of our guests and commentators are their own and do not necessarily represent the views of Community Television Foundation of South Florida, Inc. Nightly Business Report, or WPBT. Information presented on Nightly Business Report is not and should not be considered as investment advice. Copyright (c) 2005 Community Television Foundation of South Florida, Inc. ALL RIGHTS RESERVED. Terms of use.

11/15/05: "Las Vegas on a Roll,"-Part 4: The Condo Craze Reaches New Heights

JEFF YASTINE: For the last few years, Las Vegas has had the well-deserved reputation as being one of the hottest markets for single-family homes in the country. Less well known is the high-rise building boom that`s beginning to change the skyline of the city`s famous Las Vegas strip. As our series "Las Vegas on a Roll" continues, we look at what`s driving the city to go vertical. These are the sounds people hear inside the Las Vegas strip casinos. But this is the sound you`re more likely to hear outside. It`s a construction boom like no other, with cranes dotting the horizon of central Las Vegas. On the strip, off the strip, it seems high-rise condo towers are crowding into a skyline long dominated by the casino hotels. The high- rise construction trend in Las Vegas is about six years old, but it`s only really taken off in the past two years. And it`s to the point now that, by some estimates, there are more than 50 different tower projects that are either being built, proposed or planned here in the central Las Vegas area. For condo owners like Mac and Frances MacDonald, this is what it`s all about, a penthouse home in the sky, with a view to match

"MAC" & FRANCIS MACDONALD, CONDO RESIDENTS: When we entertain, people go out there. They just go out there. They stay out there. They eat. They drink. They watch the view. The view is gorgeous. At night, the view is magnificent.

YASTINE: The MacDonalds live in the first condo high-rise to be built in Las Vegas, Turnberry Towers. Completed in 1999, they were at the time a real estate novelty. People asked, why build luxury condos when the strip was lined with thousands of luxury hotel rooms? Developer Jeffrey Soffer saw something few others did at the time.

JEFFREY SOFFER, PRINCIPAL, TURNBERRY ASSOCIATES: The fact of the matter is a lot of people liked owning a place there and they want to spend time there. And I think Vegas has proven that it`s becoming a city. It`s not just a place to go hang out.

YASTINE: These days, it`s the condo developers doing the hanging out, putting up sign after sign after sign, promising high-rise condo and condo- hotels. The first of Donald Trump`s two towers is slated to finish in 2008. His ex-wife Ivana is promoting her own Vegas strip building a few miles away. This project`s first building sold out in less than two months, astounding even its own developer, a veteran of high-rise construction in New York, Miami, and now Las Vegas.

BRUCE EICHNER, CHAIRMAN & CEO, 3700 ASSOCIATES: The combined sales are just a drop under $1.7 billion in that period of time. It`s staggering. I`ve never been a participant in anything like it in my life.

YASTINE: Which leads to the question, just who`s doing the buying and for what reason? Wealthy high rollers, yes. But real estate analysts say even that`s misleading.

JACK WINSTON, REAL ESTATE ANALYST, GOODKIN RESEARCH: The idea that high-rollers are coming in from all over the country to buy units because they come to gamble a lot is not really the basis of the market. The basis of the market is the average gambler, who probably earns only $65,000, $75,000 a year.

YASTINE: According to analyst Jack Winston, much of the condo market here is being driven by investment and speculation, from just one neighboring state.

WINSTON: What is driving it is second home and weekend buyers coming in from California. California buyers represent 70 percent of all the condominiums bought so far in projects on the Las Vegas strip.

YASTINE: The latest residential concept unveiled to the press recently is Project Citycenter. MGM/Mirage is building it on a 66-acre site next to the strip. The design calls for more than 1,700 condo units, along with casino and hotel space.

ROBERT BALDWIN, PRESIDENT & CEO, MIRAGE RESORTS: Since high rise residential living in Las Vegas is relatively new over the last four or five years, it`s something that many, many people are interested in and it seems like whoever is building the high rise residentials are selling out and selling out quickly.

YASTINE: But some are sounding a note of caution about the region`s condo craze. They cite a potential oversupply of units, rising interest rates and an uncertain economy. Even veteran developers, bullish on the long-term potential here, say many of projects now being proposed will likely not get built.

SOFFER: Can Vegas handle 80,000 or 90,000 units? Probably not. But there`s not going to be 90,000 units built here. A lot of them are destined for failure. I see some of these -- these super-tallest buildings in the world and all that. I don`t think those people have a clue what they`re doing.

YASTINE: Nonetheless, in a town built on gambling, many seem more than willing to make a bet that the condo boom will continue. To learn more about Las Vegas, watch American Experience, "Las Vegas: An unconventional History" airing tonight on most PBS stations.

GHARIB: Tomorrow, it may look like cactus and scrub, but it`s really Las Vegas` next bedroom community.

Nightly Business Report transcripts are available on-line post broadcast. The program is transcribed by eMediaMillWorks. Updates may be posted at a later date. The views of our guests and commentators are their own and do not necessarily represent the views of Community Television Foundation of South Florida, Inc. Nightly Business Report, or WPBT. Information presented on Nightly Business Report is not and should not be considered as investment advice. Copyright (c) 2005 Community Television Foundation of South Florida, Inc. ALL RIGHTS RESERVED. Terms of use.

11/15/05:"Commentary"-Time To Reel In Federal Budget Policy

SUSIE GHARIB: Tonight`s commentator suggests it`s time to get a grip on America`s economic policies. Here`s Charles Schultze, senior fellow at the Brookings Institution.

CHARLES SCHULTZE, SENIOR FELLOW EMERITUS, BROOKINGS INSTITUTION: After a big jump in September, the U.S. is now approaching a monstrous $800 billion deficit in its international accounts this year as the nation increasingly spends more than it produces. This deficit has to be financed by borrowing from abroad. Elsewhere in the world, savings currently exceed domestic investment, and America is an attractive place in which to invest the surplus savings. But if we are seen as doing nothing now to curtail the growing excess of our own national spending relative to national output, there is a risk that foreigners will begin to find the U.S. a less attractive place in which to put their savings. The dollar would then fall, and interest rates rise. Domestic investment would be curtailed and American economic growth would slow. By making a substantial down payment now on a longer-term program of cutting the large Federal budget deficit, we could reduce these risks. Lately, the congressional leadership have been struggling to enact budget measures that would cut spending between $6 and $11 billion a year over the next five years. But in the face of annual budget deficits exceeding $300 billion, this is a pittance. And to make it preposterous, a companion measure would cut taxes by more than the spending reductions. Yet there are no meaningful substitutes being offered. Unfortunately, Federal budget policy is adrift. I`m Charles Schultze.

Nightly Business Report transcripts are available on-line post broadcast. The program is transcribed by eMediaMillWorks. Updates may be posted at a later date. The views of our guests and commentators are their own and do not necessarily represent the views of Community Television Foundation of South Florida, Inc. Nightly Business Report, or WPBT. Information presented on Nightly Business Report is not and should not be considered as investment advice. Copyright (c) 2005 Community Television Foundation of South Florida, Inc. ALL RIGHTS RESERVED. Terms of use.

11/15/05: "Paul Kangas' Stocks In The News"

JEFF YASTINE: And those inflation numbers and the Bernanke testimony kept a positive tone to the market early, but sellers ruled in the afternoon. The Dow notching a 40-point gain before bumping against a major chart resistance level at midday. That and a sales warning from Target, brought out the sellers. The Dow fell about 80 points. The NASDAQ fell more than 20 and then both came back somewhat in the last hour. The Dow losing just 10 3/4 points at 10,686 and a fraction. The NASDAQ closing off 14 1/4 to 2186.74 and the S&P 500 index dropping more than 4 percent to 1229. And in the bond market, the 10-year note rising 12/32 to 99 16/32, the yield at 4.56 percent.

And today we start with Johnson & Johnson (JNJ) getting a nice pop of more than $2. JNJ says it will move ahead with its purchase of Guidant but at slightly reduced terms. It will now pay about $63 a share for the company. That`s around $4 billion less than the original price and before Guidant suffered through that round of recalls of its heart assist devices.

And there`s Pfizer (PFE) dipping $0.36. A new study of Pfizer`s Lipitor drug appeared to be of little help to heart attack patients and that pushed the stock down further.

Guidant (GDT) gaining nearly $5 on that reaction from Johnson & Johnson. Guidant shareholders must still approval that lower JNJ offer.

Motorola (MOT) losing $0.32.

Advanced Micro (AMD) gaining $0.50. Its CFO expects bigger profits next year as its newest processors come to market.

And there`s the reaction for Target (TGT) shares, sliding more than $4. The retailer says it will not make its November sales growth targets of 4 to 6 percent. The announcement was a surprise given Wal-Mart`s upbeat holiday forecast yesterday and it led to a broader sell off of other retailers today.

No change in Georgia-Pacific (GP). It received that big cash buyout offer from Koch Industries over the weekend.

ExxonMobil (XOM) dipping $0.22.

Time Warner (TWX) losing $0.14.

Vodafone Group (VOD) down nearly $3. First half profits slid 19 percent. Executives cautious about next year`s results as well.

And here`s Boeing (BA) rising $0.77. The company will move ahead with the plans to build an even larger version of the 747 along with $5 billion in new orders for that configuration. It`s called the 747-8

Home Depot (HD) fall $0.17. Third quarter profits were $0.04 above estimates, but that was not quite as strong as what its rival Lowe`s posted yesterday.

IBM (IBM) jumping more than $1, mainly on news that billionaire George Soros now owns about $26 million in IBM stock.

And Agilent Technologies (A) rising $1.60. Profits rose 26 percent. In the fourth quarter, the company will also buy back more than $2.5 billion in stock.

Shares in World Fuel Services (INT) bolted $3 higher. Profits nearly doubled. Sales rising nearly 50 percent.

But Avon Products (AVP) ending off more than $2. The company wants a make over to help improve its bottom line, but that restructuring could cost as much as $500 million and that was not what investors wanted to hear.

Xerium Technologies (XRM) sank more than $2. It posted a third quarter loss of $0.18 a share.

And Jo-Ann Stores (JAS) clipped for a loss of more than $2.50. The arts and crafts retailer lowering prices during the quarter to reduce inventories, but that swung the third quarter to a loss of $0.18 a share.

Over on the NASDAQ, Google (GOOG) falling more than $4. Disappointment that Amazon and not Google will be added to the S&P 500.

Microsoft (MSFT) rising $0.23.

Apple Computer (AAPL) ended $0.83 higher.

And here`s Amazon.com (AMZN) climbing nearly $2. It will be added to the S&P on Friday.

Intel (INTC) closing out the day off $0.29.

Sandisk (SNDK) falling over $4 on a brokerage downgrade.

Dell (DELL) picking up $0.35.

Cisco Systems (CSCO) losing a fraction.

Sears Holdings (SHLD) gaining more than $2.

Qualcomm (QCOM) losing $0.59.

And finally Inamed (IMDC) soaring nearly seven bucks, the subject of another buyout offer, this time from Allergan, which is offering $84 a share in cash and that topped Medisys Pharmaceutical`s bid which was for Inamed at $75 a share. Inamed of course making, a maker of breast implants and devices used in obesity correction surgery.

And those are our stocks in the news tonight.

 

Nightly Business Report transcripts are available on-line post broadcast. The program is transcribed by eMediaMillWorks. Updates may be posted at a later date. The views of our guests and commentators are their own and do not necessarily represent the views of Community Television Foundation of South Florida, Inc. Nightly Business Report, or WPBT. Information presented on Nightly Business Report is not and should not be considered as investment advice. Copyright (c) 2005 Community Television Foundation of South Florida, Inc. ALL RIGHTS RESERVED. Terms of use.

11/15/05: Market Stats

                                      NET    PERCENT
CLOSE CHANGE CHANGE DOW CLOSE 10686.44 -10.73 - .1 HIGH 10741.99 LOW 10664.27 NASDAQ COMP. 2186.74 -14.21 -.7 HIGH 2204.69 LOW 2181.92 VOLUME 1,690.5 PREVIOUS 1,399.2 UP VOLUME 578.2 DOWN VOLUME 1,063.2 DOW TRANSPORTS 4006.16 -53.05 - 1.3 DOW UTILITIES 388.18 +1.70 + .4 CLOSING TICK +374 S&P 500 1229.01 -4.75 - .4 S&P 100 566.91 -1.90 - .3 MIDCAP 400 715.99 -3.89 - .5 REUTERS/CRB 312.73 -2.35 - .8 NYSE COMPOSITE 7509.38 -39.79 - .5 VALUE LINE 400.51 -3.20 - .8 RUSSELL 2000 656.23 -7.70 - 1.2 DJW 5000 12293.60 -60.21 - .5 U.S. TREASURIES 5-YEAR NOTE 4.50% Nov. 15,2010 99 31/32 +6/32 4.51 10-YEAR NOTE 4.50% Nov. 15,2015 99 16/32 +12/32 4.56 30-YEAR NOTE 5.375% Feb. 15, 2031 109 4/32 +24/32 4.75 LEHMAN BROS. LONG BOND INDEX 1737.59 + 3.71 DOW CLOSE 10686.44 -10.73 - .1 ADVANCES 1067 DECLINES 2245 NEW HIGHS 77 NEW LOWS 205 NET PERCENT NYSE MOST ACTIVES 4PM CLOSE CHANGE CHANGE JNJ Johnson & Johnson 62.83 +2.32 +3.8 PFE Pfizer 21.89 -.36 -1.6 GDT Guidant 62.50 +4.75 +8.2 MOT Motorola 22.54 -.32 -1.4 AMD Advanced Micro 25.50 +.50 +2.0 TGT Target 54.30 -4.13 -7.1 GP Georgia-Pacific 47.28 unch. unch. XOM Exxon Mobil 56.43 -.22 -.4 TWX Time Warner 17.62 -.14 -.8 VOD Vodafone Group 22.20 -2.95 -11.7 NASDAQ CLOSE 2186.74 - 14.21 - .7 VOLUME 1,748.2 PREVIOUS 1,430.3 ADVANCES 914 DECLINES 2116 NASDAQ ACTIVES GOOG Google 392.80 -4.17 -1.1 MSFT Microsoft 27.50 +.23 +.8 AAPL Apple Computer 62.28 +.83 +1.4 AMZN Amazon.com 44.45 +1.92 +4.5 INTC Intel 25.08 -.29 -1.1 SNDK SanDisk 57.00 -4.35 -7.1 DELL Dell 29.81 +.35 +1.2 CSCO Cisco Systems 17.27 -.08 -.5 SHLD Sears Holdings 115.80 +2.28 +2.0 QCOM Qualcomm 44.94 -.59 -1.3 AMEX CLOSE 1693.22 - 6.51 - .4 INDEX SHARES DIA DIAMONDS TRUST 107.13 -.04 -.0 QQQ NASDAQ 100 40.52 -.19 -.5 SPY S&P DEP.RECEIPTS 123.28 -.41 -.3 STOCKS IN THE NEWS BA Boeing Co 67.00 +.77 +1.2 HD Home Depot 42.40 -.17 -.4 IBM IBM 85.53 +1.17 +1.4 A Agilent Tech 34.50 +1.60 +4.9 INT World Fuel Svcs 36.00 +3.00 +9.1 AVP Avon Products 24.86 -2.22 -8.2 XRM Xerium Tech 6.85 -2.66 -28.0 JAS Jo-Ann Stores 12.37 -2.58 -17.3 IMDC Inamed 81.28 +6.84 +9.2

 

 

 

 

<%dobanner 11,1901%>

 

 

NBR appreciates the support of its national underwriters -- A.G. Edwards, Inc. and Franklin Templeton Investments. The program is produced by NBR Enterprises/WPBT2 and distributed by PBS.

   

 

Copyright © 2005 Community Television Foundation of South Florida, Inc. ALL RIGHTS RESERVED. Terms of use
Click here to contact NBR.